Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extension
多纳内单抗治疗早期症状性阿尔茨海默病:TRAILBLAZER-ALZ 2 长期扩展研究的结果
期刊:Jpad-Journal of Prevention of Alzheimers Disease
影响因子:7.8
doi:10.1016/j.tjpad.2025.100446
Zimmer, Jennifer A; Sims, John R; Evans, Cynthia D; Nery, Emel Serap Monkul; Wang, Hong; Wessels, Alette M; Tronchin, Giulia; Sato, Shoichiro; Raket, Lars Lau; Andersen, Scott W; Sapin, Christophe; Paget, Marie-Ange; Gueorguieva, Ivelina; Ardayfio, Paul; Khanna, Rashna; Brooks, Dawn A; Matthews, Brandy R; Mintun, Mark A